1. Home
  2. IGC vs AIRE Comparison

IGC vs AIRE Comparison

Compare IGC & AIRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IGC
  • AIRE
  • Stock Information
  • Founded
  • IGC 2005
  • AIRE 2021
  • Country
  • IGC United States
  • AIRE United States
  • Employees
  • IGC N/A
  • AIRE N/A
  • Industry
  • IGC Biotechnology: Pharmaceutical Preparations
  • AIRE
  • Sector
  • IGC Health Care
  • AIRE
  • Exchange
  • IGC Nasdaq
  • AIRE Nasdaq
  • Market Cap
  • IGC 39.8M
  • AIRE 39.4M
  • IPO Year
  • IGC N/A
  • AIRE N/A
  • Fundamental
  • Price
  • IGC $0.41
  • AIRE $1.25
  • Analyst Decision
  • IGC Strong Buy
  • AIRE Hold
  • Analyst Count
  • IGC 2
  • AIRE 1
  • Target Price
  • IGC $4.00
  • AIRE N/A
  • AVG Volume (30 Days)
  • IGC 1.3M
  • AIRE 32.0M
  • Earning Date
  • IGC 11-11-2025
  • AIRE 11-11-2025
  • Dividend Yield
  • IGC N/A
  • AIRE N/A
  • EPS Growth
  • IGC N/A
  • AIRE N/A
  • EPS
  • IGC N/A
  • AIRE N/A
  • Revenue
  • IGC $1,327,000.00
  • AIRE $3,043,657.00
  • Revenue This Year
  • IGC $15.26
  • AIRE $410.32
  • Revenue Next Year
  • IGC $3.41
  • AIRE $166.28
  • P/E Ratio
  • IGC N/A
  • AIRE N/A
  • Revenue Growth
  • IGC 24.95
  • AIRE 2973.28
  • 52 Week Low
  • IGC $0.25
  • AIRE $0.14
  • 52 Week High
  • IGC $0.50
  • AIRE $4.49
  • Technical
  • Relative Strength Index (RSI)
  • IGC 51.81
  • AIRE 75.96
  • Support Level
  • IGC $0.38
  • AIRE $1.13
  • Resistance Level
  • IGC $0.44
  • AIRE $1.80
  • Average True Range (ATR)
  • IGC 0.03
  • AIRE 0.19
  • MACD
  • IGC -0.00
  • AIRE 0.10
  • Stochastic Oscillator
  • IGC 32.33
  • AIRE 61.99

About IGC IGC Pharma Inc.

IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.

About AIRE reAlpha Tech Corp.

ReAlpha Tech Corp is a real estate technology company. The group is engaged in an end-to-end commission-free homebuying platform. It develops and utilizes its artificial intelligence-focused technology stack to empower retail investor participation in short-term rental properties, which are real estate units listed for a rental term. It provides short-term rental investment opportunities to everyday investors. The company has developed technologies and tools that allow for the analysis of short-term rental properties using AI to provide insight into that property's potential profitability and ways to increase such profitability. The company's reportable segments are; Platform Services and the Rental business segment.

Share on Social Networks: